Skip to main content
Clinical Trials/NCT07274683
NCT07274683
Not yet recruiting
Not Applicable

Effect of Stellate Ganglion Block on Postoperative Sleep Status in Patients With Prolonged Disorders of Consciousness: a Single--Centre Cohort Study

Beijing Tiantan Hospital1 site in 1 country25 target enrollmentStarted: January 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Beijing Tiantan Hospital
Enrollment
25
Locations
1
Primary Endpoint
Total sleep time

Overview

Brief Summary

The goal of this clinical trial is to learn about the effect of preoperative administration of stellate ganglion block on postoperative sleep status in patients with prolonged disorders of consciousness. The main aims to answer are: • To explore the effect of preoperative administration of stellate ganglion block on postoperative polysomnography and total sleep time in patients with prolonged disorders of consciousness. • To explore the effect of preoperative administration of stellate ganglion block on postoperative cerebral oxygen saturation, cerebral hemodynamic parameters and recovery of consciousness. Participants will be pDoC patients with intact skulls after acquired brain injury who will undergo spinal cord electronic stimulator implantation under general anesthesia at Beijing Tiantan Hospital. Stellate ganglion block will be administrated before the surgery. Polysomnography, total sleep time, cerebral oxygen saturation, cerebral hemodynamic parameters, CRS-R scores, GCS scores, WHIM scores and NCS scores will be investigated.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Aged 18-65 years;
  • Prolonged disorders of consciousness after acquired brain injury;
  • Scheduled to undergo spinal cord electronic stimulator implantation under general anesthesia;
  • The skull is intact;
  • Informed consent is obtained;

Exclusion Criteria

  • Continuous sedation therapy is performed within 72 hours prior to the study;
  • The integrity of brain structure is disrupted due to causes such as open head injury and cerebral parenchymal resection;
  • Decreased intracranial compliance caused by hydrocephalus and other reasons;
  • Airway stenosis or severe dysfunction of ventilation or gas exchange due to various causes;
  • Known or suspected severe cardiac, pulmonary, and renal dysfunction;
  • History of sedative drug allergy;
  • Complicated by other mental or neurological disorders;
  • Local anesthetic allergy;
  • Other reasons for ineligibility in this study;
  • Informed consent is not obtained;

Arms & Interventions

stellate ganglion block

preoperative administration of stellate ganglion block

Intervention: stellate ganglion block with 0.5% ropivacaine (Drug)

Outcomes

Primary Outcomes

Total sleep time

Time Frame: on the first postoperative night

total sleep time on PSG

Secondary Outcomes

  • Length of ICU stay(30 days postoperatively)
  • cerebral oxygen saturation(30 minutes after stellate ganglion block)
  • cerebral hemodynamic parameters(30 minutes after stellate ganglion block.)
  • the recovery of consciousness(1 and 30 days postoperatively)
  • Costs of ICU stay(30 days postoperatively)

Investigators

Sponsor
Beijing Tiantan Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ruquan Han

Director

Beijing Tiantan Hospital

Study Sites (1)

Loading locations...

Similar Trials